Irma Bagdoniene on NEJM-Published VESALIUS-CV: 25% Fewer First CV Events
Irma Bagdoniene, Cardiologist and Lipidologist at Klinikum Lippe – University Hospital for Cardiology, Angiology, and Internal Intensive Care Medicine, posted on LinkedIn:
”VESALIUS-CV at AHA:
The Room Was Applauding – And Not Without Reason
Presented at the AHA Congress and now published in NEJM, VESALIUS-CV marks a turning point in preventive cardiology.
In patients without prior MI or stroke, evolocumab reduced first major cardiovascular events by 25% — safely and decisively.
LDL lowering works – and earlier intervention saves lives.
When an entire audience of cardiologists applauds, it’s not hype. It’s the sound of a paradigm shifting.”
Read the full article here.
Title: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
Authors: Erin A. Bohula, D.Phil., Nicholas A. Marston, Ajay K. Bhatia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Jeong-Gun Park, Julia F. Kuder, Sabina A. Murphy, Emileigh Walsh, Huei Wang, Vladimir Blaha, Andrzej Budaj, Jan H. Cornel, Assen Goudev, Robert Gabor Kiss, Alberto J. Lorenzatti, Alexander Parkhomenko, Marcoli Cyrille, Gabriel Paiva da Silva Lima, E. Magnus Ohman, Robert P. Giugliano, Marc S. Sabatine

Stay updated with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy
